The Discounted Cash Flow (DCF) valuation of Surgery Partners Inc (SGRY) is 32.52 USD. With the latest stock price at 22.74 USD, the upside of Surgery Partners Inc based on DCF is 43.0%.
Based on the latest price of 22.74 USD and our DCF valuation, Surgery Partners Inc (SGRY) is a buy. buying SGRY stocks now will result in a potential gain of 43.0%.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 7.1% | 7.0% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 21.17 - 52.90 | 32.52 |
| Upside | -6.9% - 132.6% | 43.0% |